Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00985439Phase 2Completed
Phase 2, randomised, double-blind trial of diclofenac in odontalgia (4 arms), sponsored by Iroko Pharmaceuticals, LLC. Primary endpoint: Total Patient Pain Relief Over 0 to 12 Hours. Started Sep 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00985439.